Howard Lee Ph.D


Howard Lee, Ph.D. has served as a member of our Board of Directors since August 2007. He previously served as a member of the Board of one of our subsidiaries from 1998 to 2002 and Amphastar’s Board from 2002 to 2004. Dr. Lee is currently the partner at the CID Group, a prominent investment group in the greater China area.  His previous commitment was the Chief Investment Officer at UniMed Venture Management Inc., a biotech venture capital firm. Prior to joining UniMed in July 2009, he was a Managing Director at Silver Biotech Management, Inc. for three years. Dr. Lee served as President and CEO of CDIB Biotech USA Investment Co. Ltd. from October 2000 to June 2006 and as Vice President of China Development Industrial Bank, a prominent investment bank in Taiwan, from October 1995 to June 2006. He carries broad industrial experience from conducting environmental engineering projects in diversified industries since 1993. He also serves as a director for the Development Center of Biotechnology in Taiwan. Dr. Lee earned his B.Sc. at Fu-Jen University (Taiwan), his M.Sc. and Ph.D. degrees in Chemistry from the University of Southern California in Los Angeles in 1990, and completed his postdoctoral research at Loker Hydrocarbon Research Institute of USC.


Copyright ©2020 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States